Cargando…
M1 macrophage-derived exosomes synergistically enhance the anti- bladder cancer effect of gemcitabine
Gemcitabine (GEM) is one of the first choice drugs for treating bladder cancer. In this study, we loaded M1 macrophage-derived exosomes (M1-Exo) with GEM by ultrasonication technique to derive an M1-Exo-GEM drug delivery system, and then explored its effects on bladder cancer. After inducing M1 pola...
Autores principales: | Tang, Zhiling, Tang, Chenye, Sun, Chun, Ying, Xiangjun, Shen, Ruilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550252/ https://www.ncbi.nlm.nih.gov/pubmed/35929830 http://dx.doi.org/10.18632/aging.204200 |
Ejemplares similares
-
M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
por: Zhao, Yongmei, et al.
Publicado: (2021) -
Short-term mortality risks among patients with non-metastatic bladder cancer
por: Zhai, Menghe, et al.
Publicado: (2020) -
In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients
por: Mey, V, et al.
Publicado: (2006) -
Sunitinib Malate Synergistically Potentiates Anti-Tumor Effect of Gemcitabine in Human Bladder Cancer Cells
por: Yoon, Cheol Yong, et al.
Publicado: (2011) -
Association between acute kidney injury and prognoses of cardiac surgery patients: Analysis of the MIMIC-III database
por: Sun, Chun, et al.
Publicado: (2023)